Friday, November 28, 2008
Cancer researchers change focus to target the more stubborn killers - UK news item
Cancer researchers change focus to target the more stubborn killers - Health News, Health & Wellbeing - The Independent
"Mr Kumar said: 'Growing obesity cannot be the whole explanation [for the rise] because our rates are higher than in the US and obesity is a bigger problem there.'"
EvidenceUpdates - Risk of Venous Thromboembolism with the Angiogenesis Inhibitor Bevacizumab (Avastin) in Cancer Patients: A Meta-analysis
New Articles -- EvidenceUpdates
"CONCLUSION: The use of bevacizumab was significantly associated with an increased risk of developing venous thromboembolism in cancer patients receiving this drug."
Subscribe to:
Posts
(
Atom
)
Posts
